Alzheimer’s Disease :: Mayo Clinic joins Nationwide Clinical Trial testing Omega-3 Fatty Acids in the fight against Alzheimer’s Disease
A Mayo Clinic research team led by neurologist David Knopman, M.D. will join a nationwide consortium of leading Alzheimer’s disease researchers in a large-scale clinical trial evaluating the effectiveness of omega-3 fatty acids in slowing the progression of Alzheimer’s disease.